AGIO


Time to Pull the Trigger? RBC Offers 2 Stocks to Buy

For the first time ever, investment firm RBC Capital released its Small-Cap Growth Idea list, made up of stocks with market caps below …

3 Top Healthcare Stocks That Could Gain 35% — Or More

Returns, that’s the name of the investing game. At the end of the day, investors are after the names that can help them …

3 Beaten Stocks to Buy on the Dip

Don’t count all beaten-down stocks out just yet. We mean the names that have seen share prices trend lower as a result of …

Stock Update (NASDAQ:AGIO): Agios Pharmaceuticals Inc Outlines Key Upcoming Milestones Amid Evolution To Commercial Stage Biopharmaceutical Company

Agios Pharmaceuticals Inc (NASDAQ:AGIO) outlined key 2017 milestones in conjunction with its presentation at the 35th Annual J.P.

Stock Update (NASDAQ:AGIO): Agios Pharmaceuticals Inc Appoints Ian Clark to Board of Directors

Agios Pharmaceuticals Inc (NASDAQ: AGIO) announced the appointment of Ian Clark to its board of directors. Most recently, Mr.

Canaccord Lays Out the Bullish Case for Agios Pharmaceuticals Inc (AGIO) Despite IND Withdrawal

Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares were thundering down 19% yesterday after news came to light that the firm has withdrawn its Investigational New …

Canaccord Chimes In On Agios Pharmaceuticals Inc (AGIO) Following ASH Event

In a research report published Monday, Canaccord analyst John Newman reiterated a Buy rating on shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO), with a …

Stock Update (NASDAQ:AGIO): Agios Pharmaceuticals Inc Announces Proposed Offering of Common Stock

Agios Pharmaceuticals Inc (NASDAQ:AGIO) announced that it is offering to sell, subject to market and other conditions, up to $150 million of its …

Canaccord Positive on Agios Pharmaceuticals Inc (AGIO) on Back of NDA Filing

Agios Pharmaceuticals Inc (NASDAQ:AGIO) announced that its collaboration partner Celgene Corporation (NASDAQ:CELG) intends to file for an NDA for its AML-treating drug AG-221 …

Company Update (NASDAQ:AGIO): Agios Pharmaceuticals Inc Appoints Andrew Hirsch as Chief Financial Officer

Agios Pharmaceuticals Inc (NASDAQ:AGIO), a leader in the fields of cancer metabolism and rare genetic metabolic disorders, announced that Andrew Hirsch is joining the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts